1 Chronic Obstructive Pulmonary Disease (COPD) Drugs Introduction and Market Overview 1.1 Objectives of the Study 1.2 Definition of Chronic Obstructive Pulmonary Disease (COPD) Drugs 1.3 Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Scope and Market Size Estimation 1.3.1 Market Concentration Ratio and Market Maturity Analysis 1.3.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Value and Growth Rate from 2014-2024 1.4 Market Segmentation 1.4.1 Types of Chronic Obstructive Pulmonary Disease (COPD) Drugs 1.4.2 Applications of Chronic Obstructive Pulmonary Disease (COPD) Drugs 1.4.3 Research Countries 1.5 Market Dynamics 1.5.1 Drivers 1.5.2 Limitations 1.5.3 Opportunities 1.6 Industry News and Policies by Countries 1.6.1 Industry News 1.6.2 Industry Policies 2 Industry Chain Analysis 2.1 Upstream Raw Material Suppliers of Chronic Obstructive Pulmonary Disease (COPD) Drugs Analysis 2.2 Major Players of Chronic Obstructive Pulmonary Disease (COPD) Drugs 2.2.1 Major Players Manufacturing Base and Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs in 2018 2.2.2 Major Players Product Types in 2018 2.3 Chronic Obstructive Pulmonary Disease (COPD) Drugs Manufacturing Cost Structure Analysis 2.3.1 Consumption Process Analysis 2.3.2 Manufacturing Cost Structure of Chronic Obstructive Pulmonary Disease (COPD) Drugs 2.3.3 Raw Material Cost of Chronic Obstructive Pulmonary Disease (COPD) Drugs 2.3.4 Labor Cost of Chronic Obstructive Pulmonary Disease (COPD) Drugs 2.4 Market Channel Analysis of Chronic Obstructive Pulmonary Disease (COPD) Drugs 2.5 Major Downstream Buyers of Chronic Obstructive Pulmonary Disease (COPD) Drugs Analysis 3 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Market, by Type 3.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Value and Market Share by Type (2014-2019E) 3.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Market Share by Type (2014-2019E) 3.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Value and Growth Rate by Type (2014-2019E) 3.3.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Value and Growth Rate of anticholinergic 3.3.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Value and Growth Rate of oral corticosteroid 3.3.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Value and Growth Rate of beta2-agonists 3.3.4 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Value and Growth Rate of phosphodiesterase-4 (PDE4) inhibitors 3.3.5 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Value and Growth Rate of others 3.4 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Price Analysis by Type (2014-2019E) 4 Chronic Obstructive Pulmonary Disease (COPD) Drugs Market, by Application 4.1 Downstream Market Overview 4.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Market Share by Application (2014-2019E) 4.2.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Growth Rate of lung functional test (2014-2019E) 4.2.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Growth Rate of chest x-ray test (2014-2019E) 4.2.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Growth Rate of CT scan (2014-2019E) 4.2.4 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Growth Rate of others (2014-2019E) 5 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption, Value ($) by Countries (2014-2019E) 5.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Value and Market Share by Countries (2014-2019E) 5.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Market Share by Countries (2014-2019E) 5.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 5.4 Germany Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 5.5 UK Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 5.6 France Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 5.7 Italy Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 5.8 Spain Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 5.9 Russia Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 6 Competitive Landscape 6.1 Competitive Profile 6.2 Astellas Pharma 6.2.1 Company Profiles 6.2.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Introduction 6.2.3 Astellas Pharma Sales, Value, Price, Gross Margin 2014-2019E 6.2.4 Astellas Pharma Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 6.3 Pharmaxis 6.3.1 Company Profiles 6.3.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Introduction 6.3.3 Pharmaxis Sales, Value, Price, Gross Margin 2014-2019E 6.3.4 Pharmaxis Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 6.4 AstraZeneca 6.4.1 Company Profiles 6.4.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Introduction 6.4.3 AstraZeneca Sales, Value, Price, Gross Margin 2014-2019E 6.4.4 AstraZeneca Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 6.5 Invion 6.5.1 Company Profiles 6.5.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Introduction 6.5.3 Invion Sales, Value, Price, Gross Margin 2014-2019E 6.5.4 Invion Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 6.6 F. Hoffmann-La Roche 6.6.1 Company Profiles 6.6.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Introduction 6.6.3 F. Hoffmann-La Roche Sales, Value, Price, Gross Margin 2014-2019E 6.6.4 F. Hoffmann-La Roche Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 6.7 Novartis 6.7.1 Company Profiles 6.7.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Introduction 6.7.3 Novartis Sales, Value, Price, Gross Margin 2014-2019E 6.7.4 Novartis Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 6.8 Mereo BioPharma 6.8.1 Company Profiles 6.8.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Introduction 6.8.3 Mereo BioPharma Sales, Value, Price, Gross Margin 2014-2019E 6.8.4 Mereo BioPharma Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 6.9 Asmacure 6.9.1 Company Profiles 6.9.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Introduction 6.9.3 Asmacure Sales, Value, Price, Gross Margin 2014-2019E 6.9.4 Asmacure Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 6.10 Palobiofarma 6.10.1 Company Profiles 6.10.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Introduction 6.10.3 Palobiofarma Sales, Value, Price, Gross Margin 2014-2019E 6.10.4 Palobiofarma Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 6.11 Ache Laboratorios Farmaceuticos 6.11.1 Company Profiles 6.11.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Introduction 6.11.3 Ache Laboratorios Farmaceuticos Sales, Value, Price, Gross Margin 2014-2019E 6.11.4 Ache Laboratorios Farmaceuticos Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 6.12 Chiesi Farmaceutici 6.12.1 Company Profiles 6.12.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Introduction 6.12.3 Chiesi Farmaceutici Sales, Value, Price, Gross Margin 2014-2019E 6.12.4 Chiesi Farmaceutici Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 6.13 Cytokinetics 6.13.1 Company Profiles 6.13.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Introduction 6.13.3 Cytokinetics Sales, Value, Price, Gross Margin 2014-2019E 6.13.4 Cytokinetics Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 6.14 Innoviva 6.14.1 Company Profiles 6.14.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Introduction 6.14.3 Innoviva Sales, Value, Price, Gross Margin 2014-2019E 6.14.4 Innoviva Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 6.15 Ario Pharma 6.15.1 Company Profiles 6.15.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Introduction 6.15.3 Ario Pharma Sales, Value, Price, Gross Margin 2014-2019E 6.15.4 Ario Pharma Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 6.16 Orion Corporation 6.16.1 Company Profiles 6.16.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Introduction 6.16.3 Orion Corporation Sales, Value, Price, Gross Margin 2014-2019E 6.16.4 Orion Corporation Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 6.17 Pearl Therapeutics 6.18 Aquinox Pharmaceuticals 6.19 Boehringer Ingelheim 6.20 Almirall 6.21 Gilead Sciences 6.22 ZAI Lab 6.23 Merck 6.24 Prosonix 6.25 Mylan 6.26 MediciNova 6.27 BioMarck Pharmaceuticals 7 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Analysis and Forecast by Type and Application 7.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Value & Volume Forecast, by Type (2019-2024) 7.1.1 anticholinergic Market Value and Volume Forecast (2019-2024) 7.1.2 oral corticosteroid Market Value and Volume Forecast (2019-2024) 7.1.3 beta2-agonists Market Value and Volume Forecast (2019-2024) 7.1.4 phosphodiesterase-4 (PDE4) inhibitors Market Value and Volume Forecast (2019-2024) 7.1.5 others Market Value and Volume Forecast (2019-2024) 7.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Value & Volume Forecast, by Application (2019-2024) 7.2.1 lung functional test Market Value and Volume Forecast (2019-2024) 7.2.2 chest x-ray test Market Value and Volume Forecast (2019-2024) 7.2.3 CT scan Market Value and Volume Forecast (2019-2024) 7.2.4 others Market Value and Volume Forecast (2019-2024) 8 Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Analysis and Forecast by Countries 8.1 Germany Market Value and Consumption Forecast (2019-2024) 8.2 UK Market Value and Consumption Forecast (2019-2024) 8.3 France Market Value and Consumption Forecast (2019-2024) 8.4 Italy Market Value and Consumption Forecast (2019-2024) 8.5 Spain Market Value and Consumption Forecast (2019-2024) 8.6 Russia Market Value and Consumption Forecast (2019-2024) 9 New Project Feasibility Analysis 9.1 Industry Barriers and New Entrants SWOT Analysis 9.2 Analysis and Suggestions on New Project Investment 10 Research Finding and Conclusion 11 Appendix 11.1 Methodology 11.2 Research Data Source

List of Tables and Figures Figure Product Picture of Chronic Obstructive Pulmonary Disease (COPD) Drugs Table Product Specification of Chronic Obstructive Pulmonary Disease (COPD) Drugs Figure Market Concentration Ratio and Market Maturity Analysis of Chronic Obstructive Pulmonary Disease (COPD) Drugs Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Value ($) and Growth Rate from 2014-2024 Table Different Types of Chronic Obstructive Pulmonary Disease (COPD) Drugs Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Value ($) Segment by Type from 2014-2019E Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Types in 2018 Figure anticholinergic Picture Figure oral corticosteroid Picture Figure beta2-agonists Picture Figure phosphodiesterase-4 (PDE4) inhibitors Picture Figure others Picture Table Different Applications of Chronic Obstructive Pulmonary Disease (COPD) Drugs Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Value ($) Segment by Applications from 2014-2019E Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Applications in 2018 Figure lung functional test Picture Figure chest x-ray test Picture Figure CT scan Picture Figure others Picture Table Research Countries of Chronic Obstructive Pulmonary Disease (COPD) Drugs Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Countries in 2018 Figure Germany Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Value ($) and Growth Rate (2014-2019E) Figure UK Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Value ($) and Growth Rate (2014-2019E) Figure France Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Value ($) and Growth Rate (2014-2019E) Figure Italy Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Value ($) and Growth Rate (2014-2019E) Figure Spain Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Value ($) and Growth Rate (2014-2019E) Figure Russia Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Value ($) and Growth Rate (2014-2019E) Table Emerging and Growing Market of Chronic Obstructive Pulmonary Disease (COPD) Drugs Table Industry News Table Industry Policies Figure Industry Chain Analysis of Chronic Obstructive Pulmonary Disease (COPD) Drugs Table Upstream Raw Material Suppliers of Chronic Obstructive Pulmonary Disease (COPD) Drugs with Contact Information Table Major Players Manufacturing Base and Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs in 2018 Table Major Players Consumption Value Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs in 2018 Table Major Players Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Types in 2018 Figure Consumption Process of Chronic Obstructive Pulmonary Disease (COPD) Drugs Figure Manufacturing Cost Structure of Chronic Obstructive Pulmonary Disease (COPD) Drugs Figure Channel Status of Chronic Obstructive Pulmonary Disease (COPD) Drugs Table Major Distributors of Chronic Obstructive Pulmonary Disease (COPD) Drugs with Contact Information Table Major Downstream Buyers of Chronic Obstructive Pulmonary Disease (COPD) Drugs with Contact Information Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Value ($) by Type (2014-2019E) Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Value Share by Type (2014-2019E) Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Value Share by Type (2014-2019E) Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption by Type (2014-2019E) Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Share by Type (2014-2019E) Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Share by Type (2014-2019E) Figure anticholinergic Picture Figure oral corticosteroid Picture Figure beta2-agonists Picture Figure phosphodiesterase-4 (PDE4) inhibitors Picture Figure others Picture Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Value ($) and Growth Rate of others Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Price by Type (2014-2019E) Figure Downstream Market Overview Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption by Application (2014-2019E) Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Market Share by Application (2014-2019E) Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Market Share by Application (2014-2019E) Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Growth Rate of lung functional test (2014-2019) Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Growth Rate of chest x-ray test (2014-2019) Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Growth Rate of CT scan (2014-2019) Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Growth Rate of others (2014-2019) Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Value ($) by Countries (2014-2019E) Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Value Market Share by Countries (2014-2019E) Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Value Market Share by Countries (2014-2019E) Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption by Countries (2014-2019E) Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Market Share by Countries (2014-2019E) Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Market Share by Countries (2014-2019E) Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Table Germany Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Table UK Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Table France Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Table Italy Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Table Spain Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Table Russia Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Figure Top 3 Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Companies in 2018 Figure Top 6 Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Companies in 2018 Table Major Players Value ($) Share (2014-2019E) Table Company Profiles Table Product Introduction Table Astellas Pharma Sales, Value, Price, Gross Margin 2014-2019E Figure Astellas Pharma Sales and Growth Rate Figure Astellas Pharma Value ($) Market Share 2014-2019 Figure Astellas Pharma Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Pharmaxis Sales, Value, Price, Gross Margin 2014-2019E Figure Pharmaxis Sales and Growth Rate Figure Pharmaxis Value ($) Market Share 2014-2019 Figure Pharmaxis Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table AstraZeneca Sales, Value, Price, Gross Margin 2014-2019E Figure AstraZeneca Sales and Growth Rate Figure AstraZeneca Value ($) Market Share 2014-2019 Figure AstraZeneca Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Invion Sales, Value, Price, Gross Margin 2014-2019E Figure Invion Sales and Growth Rate Figure Invion Value ($) Market Share 2014-2019 Figure Invion Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table F. Hoffmann-La Roche Sales, Value, Price, Gross Margin 2014-2019E Figure F. Hoffmann-La Roche Sales and Growth Rate Figure F. Hoffmann-La Roche Value ($) Market Share 2014-2019 Figure F. Hoffmann-La Roche Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Novartis Sales, Value, Price, Gross Margin 2014-2019E Figure Novartis Sales and Growth Rate Figure Novartis Value ($) Market Share 2014-2019 Figure Novartis Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Mereo BioPharma Sales, Value, Price, Gross Margin 2014-2019E Figure Mereo BioPharma Sales and Growth Rate Figure Mereo BioPharma Value ($) Market Share 2014-2019 Figure Mereo BioPharma Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Asmacure Sales, Value, Price, Gross Margin 2014-2019E Figure Asmacure Sales and Growth Rate Figure Asmacure Value ($) Market Share 2014-2019 Figure Asmacure Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Palobiofarma Sales, Value, Price, Gross Margin 2014-2019E Figure Palobiofarma Sales and Growth Rate Figure Palobiofarma Value ($) Market Share 2014-2019 Figure Palobiofarma Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Ache Laboratorios Farmaceuticos Sales, Value, Price, Gross Margin 2014-2019E Figure Ache Laboratorios Farmaceuticos Sales and Growth Rate Figure Ache Laboratorios Farmaceuticos Value ($) Market Share 2014-2019 Figure Ache Laboratorios Farmaceuticos Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Chiesi Farmaceutici Sales, Value, Price, Gross Margin 2014-2019E Figure Chiesi Farmaceutici Sales and Growth Rate Figure Chiesi Farmaceutici Value ($) Market Share 2014-2019 Figure Chiesi Farmaceutici Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Cytokinetics Sales, Value, Price, Gross Margin 2014-2019E Figure Cytokinetics Sales and Growth Rate Figure Cytokinetics Value ($) Market Share 2014-2019 Figure Cytokinetics Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Innoviva Sales, Value, Price, Gross Margin 2014-2019E Figure Innoviva Sales and Growth Rate Figure Innoviva Value ($) Market Share 2014-2019 Figure Innoviva Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Ario Pharma Sales, Value, Price, Gross Margin 2014-2019E Figure Ario Pharma Sales and Growth Rate Figure Ario Pharma Value ($) Market Share 2014-2019 Figure Ario Pharma Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Orion Corporation Sales, Value, Price, Gross Margin 2014-2019E Figure Orion Corporation Sales and Growth Rate Figure Orion Corporation Value ($) Market Share 2014-2019 Figure Orion Corporation Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Pearl Therapeutics Sales, Value, Price, Gross Margin 2014-2019E Figure Pearl Therapeutics Sales and Growth Rate Figure Pearl Therapeutics Value ($) Market Share 2014-2019 Figure Pearl Therapeutics Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Aquinox Pharmaceuticals Sales, Value, Price, Gross Margin 2014-2019E Figure Aquinox Pharmaceuticals Sales and Growth Rate Figure Aquinox Pharmaceuticals Value ($) Market Share 2014-2019 Figure Aquinox Pharmaceuticals Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Boehringer Ingelheim Sales, Value, Price, Gross Margin 2014-2019E Figure Boehringer Ingelheim Sales and Growth Rate Figure Boehringer Ingelheim Value ($) Market Share 2014-2019 Figure Boehringer Ingelheim Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Almirall Sales, Value, Price, Gross Margin 2014-2019E Figure Almirall Sales and Growth Rate Figure Almirall Value ($) Market Share 2014-2019 Figure Almirall Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Gilead Sciences Sales, Value, Price, Gross Margin 2014-2019E Figure Gilead Sciences Sales and Growth Rate Figure Gilead Sciences Value ($) Market Share 2014-2019 Figure Gilead Sciences Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table ZAI Lab Sales, Value, Price, Gross Margin 2014-2019E Figure ZAI Lab Sales and Growth Rate Figure ZAI Lab Value ($) Market Share 2014-2019 Figure ZAI Lab Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Merck Sales, Value, Price, Gross Margin 2014-2019E Figure Merck Sales and Growth Rate Figure Merck Value ($) Market Share 2014-2019 Figure Merck Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Prosonix Sales, Value, Price, Gross Margin 2014-2019E Figure Prosonix Sales and Growth Rate Figure Prosonix Value ($) Market Share 2014-2019 Figure Prosonix Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Mylan Sales, Value, Price, Gross Margin 2014-2019E Figure Mylan Sales and Growth Rate Figure Mylan Value ($) Market Share 2014-2019 Figure Mylan Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table MediciNova Sales, Value, Price, Gross Margin 2014-2019E Figure MediciNova Sales and Growth Rate Figure MediciNova Value ($) Market Share 2014-2019 Figure MediciNova Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table BioMarck Pharmaceuticals Sales, Value, Price, Gross Margin 2014-2019E Figure BioMarck Pharmaceuticals Sales and Growth Rate Figure BioMarck Pharmaceuticals Value ($) Market Share 2014-2019 Figure BioMarck Pharmaceuticals Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs Segmented by Region in 2018 Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Value ($) Forecast, by Type Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Volume Forecast, by Type Table Europe Market Value ($) Forecast by Application (2019-2024) Table Europe Market Volume Forecast by Application (2019-2024) Figure Germany Market Value ($) and Growth Rate Forecast (2019-2024) Figure Germany Consumption and Growth Rate Forecast (2019-2024) Figure UK Market Value ($) and Growth Rate Forecast (2019-2024) Figure UK Consumption and Growth Rate Forecast (2019-2024) Figure France Market Value ($) and Growth Rate Forecast (2019-2024) Figure France Consumption and Growth Rate Forecast (2019-2024) Figure Italy Market Value ($) and Growth Rate Forecast (2019-2024) Figure Italy Consumption and Growth Rate Forecast (2019-2024) Figure Spain Market Value ($) and Growth Rate Forecast (2019-2024) Figure Spain Consumption and Growth Rate Forecast (2019-2024) Figure Russia Market Value ($) and Growth Rate Forecast (2019-2024) Figure Russia Consumption and Growth Rate Forecast (2019-2024) Figure Industry Resource/Technology/Labor Importance Analysis Table New Entrants SWOT Analysis Table New Project Analysis of Investment Recovery